ArticleThe Cochrane database of systematic reviews2026

Dose reduction and discontinuation of non-tumor necrosis factor (TNF) biologic and targeted synthetic disease-modifying antirheumatic drugs (DMARDs) for people with rheumatoid arthritis in remission or low disease activity.

Yuanteng J Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.